Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W3XP
|
||||
| Former ID |
DNC009464
|
||||
| Drug Name |
Garveatin C
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528499] | ||
| Formula |
C22H24O5
|
||||
| Canonical SMILES |
CC1=CC2=CC3=C(C(=C2C(=C1C(=O)C)OC)O)C(=O)C(C(=O)C3(C)C)<br />(C)C
|
||||
| InChI |
1S/C22H24O5/c1-10-8-12-9-13-16(19(25)22(5,6)20(26)21(13,3)4)17(24)15(12)18(27-7)14(10)11(2)23/h8-9,24H,1-7H3
|
||||
| InChIKey |
BRECKZGJFRHNPM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Indoleamine 2,3-dioxygenase | Target Info | Inhibitor | [528499] | |
| PathWhiz Pathway | Tryptophan Metabolism | ||||
| Reactome | Tryptophan catabolism | ||||
| References | |||||